S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine
Calcium channel blockers are among the first-line drugs for treatment of hypertension (HTN). S-amlodipine (S-AM), an S-enantiomer of amlodipine, is available in India and in other countries like China, Korea, Russia, Ukraine, and Nepal. Being clinically researched for nearly two decades, we performe...
Saved in:
Main Authors: | Jamshed Dalal, J. C. Mohan, S. S. Iyengar, Jagdish Hiremath, Immaneni Sathyamurthy, Sandeep Bansal, Dhiman Kahali, Arup Dasbiswas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2018/8681792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Untypical Amlodipine-Induced Gingival Hyperplasia
by: Verica Pavlic, et al.
Published: (2015-01-01) -
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
by: Steen Neldam, et al.
Published: (2013-01-01) -
Severe Rhabdomyolysis Associated with Simvastatin and Role of
Ciprofloxacin and Amlodipine Coadministration
by: Nicolas De Schryver, et al.
Published: (2015-01-01) -
Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, Randomized Controlled Trial
by: Hongjie Chi, et al.
Published: (2025-01-01) -
Development and Evaluation of Amlodipine-Polymer Nanocomposites Using Response Surface Methodology
by: Zain Alabden Ghanim Ahmed, et al.
Published: (2022-01-01)